Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)
Patricia A. H. Hamers, Geraldine R. Vink, Marloes A.G. Elferink, Rebecca K. Stellato, Willemieke P.M. Dijksterhuis, Cornelis J.A. Punt, Miriam Koopman, Anne M. May, Laurens V. Beerepoot, Geert-Jan Creemers, Hester van Cruijsen, Jan Willem B. de Groot, Henk K. van Halteren, Helgi H. Helgason, Mathijs P. Hendriks, Ronald Hoekstra, Lieke H. van Huis‐Tanja, Ellen Kapiteijn, Maartje Los, Esther van Meerten, Natascha A. J. B. Peters, Hans Pruijt, Patricia Quarles van Ufford-Mannesse, Mark P.S. Sie, Dirkje W. Sommeijer, Leontine E.A.M.M. Spierings, Frederiek Terheggen, Manuel L. R. Tjin‐A‐Ton, Liselot Valkenburg‐van Iersel, Theo van Voorthuizen, Judith de Vos‐Geelen, Annelie J.E. Vulink, Agnès J. van de Wouw
Topics & Concepts
MedicineQuality of life (healthcare)Internal medicineColorectal cancerClinical endpointCohortPlaceboProportional hazards modelCancerProspective cohort studyOncologyClinical trialProgression-free survivalOverall survivalSurgeryPathologyNursingAlternative medicineColorectal Cancer Treatments and StudiesEconomic and Financial Impacts of CancerCancer survivorship and care